PMID- 36124489 OWN - NLM STAT- MEDLINE DCOM- 20230126 LR - 20230422 IS - 1998-4049 (Electronic) IS - 1319-3767 (Print) IS - 1319-3767 (Linking) VI - 29 IP - 1 DP - 2023 Jan-Feb TI - Factors and techniques associated with endoscopic retrograde cholangiopancreatography outcomes in patients with periampullary diverticulum: Results from a large tertiary center. PG - 12-20 LID - 10.4103/sjg.sjg_311_22 [doi] AB - BACKGROUND: Endoscopic retrograde cholangiopancreatography (ERCP) for patients with periampullary diverticulum (PAD) remains a challenge. This study aims to investigate the factors and techniques related to successful and safe ERCP in patients with PAD. METHODS: We enrolled patients who underwent ERCP in a large tertiary center. The difficult cannulation rate, technical success rate, clinical success rate, and adverse events (AEs) rate were compared between patients with or without PAD. Three independent logistic regression models were established to identify factors and techniques associated with difficult cannulation, clinical success, and AEs. RESULTS: Five thousand five hundred and ninety patients were included, of which 705 (12.6%) were diagnosed with PAD. Patients with PAD had a significantly higher difficult cannulation rate compared with patients without PAD (10.6% vs 8.0%, P < 0.0001), but the rates of technical success (clinical success (95.2% vs 95.2%, P = 0.951), and AEs (16.5% vs 14.4%, P = 0.156) were similar. Type I PAD (odds ratio [OR] = 2.114, 95% confidence interval [CI]:1.05-5.25) and ERCP indication for pancreatic diseases (OR = 1.196, 95%CI: 1.053-1.261) were independently associated with difficult cannulation. Small endoscopic sphincterotomy (EST) with balloon dilatation (OR = 1.581, 95%CI: 1.044-2.393) was independently associated with clinical success. Somatostatin injection showed no preventive effect on post-ERCP pancreatitis (OR = 1.144, 95%CI: 1.044-1.254). Moreover, the auxiliary cannulation techniques were safe for PAD patients. CONCLUSIONS: PAD did not affect ERCP outcomes. However, the choice of techniques and AE prophylactic measures should be more specific, especially for patients with type I PAD. FAU - Xia, Chuanchao AU - Xia C AD - Department of Gastroenterology, Changhai Hospital, Second Military Medical University, Shanghai, China. FAU - Sun, Liqi AU - Sun L AD - Department of Gastroenterology, Changhai Hospital, Second Military Medical University, Shanghai; Department of Gastroenterology, 72th Group Army Hospital, Huzhou University, Huzhou, Zhejiang Province, China. FAU - Peng, Lisi AU - Peng L AD - Department of Gastroenterology, Changhai Hospital, Second Military Medical University, Shanghai, China. FAU - Cui, Fang AU - Cui F AD - Department of Gastroenterology, Changhai Hospital, Second Military Medical University, Shanghai; Department of Gastroenterology, 72th Group Army Hospital, Huzhou University, Huzhou, Zhejiang Province, China. FAU - Jin, Zhendong AU - Jin Z AD - Department of Gastroenterology, Changhai Hospital, Second Military Medical University, Shanghai, China. FAU - Huang, Haojie AU - Huang H AD - Department of Gastroenterology, Changhai Hospital, Second Military Medical University, Shanghai, China. LA - eng PT - Journal Article PL - India TA - Saudi J Gastroenterol JT - Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association JID - 9516979 SB - IM MH - Humans MH - Cholangiopancreatography, Endoscopic Retrograde/adverse effects/methods MH - *Ampulla of Vater/surgery MH - Treatment Outcome MH - Catheterization/adverse effects/methods MH - Sphincterotomy, Endoscopic/adverse effects/methods MH - *Duodenal Diseases/etiology/surgery MH - *Diverticulum/surgery/etiology MH - Retrospective Studies PMC - PMC10117011 OTO - NOTNLM OT - Adverse events (AEs) OT - clinical success rate OT - difficult cannulation OT - endoscopic retrograde cholangiopancreatography (ERCP) OT - periampullary diverticulum (PAD) COIS- None EDAT- 2022/09/21 06:00 MHDA- 2023/01/27 06:00 PMCR- 2022/09/16 CRDT- 2022/09/20 03:23 PHST- 2022/09/21 06:00 [pubmed] PHST- 2023/01/27 06:00 [medline] PHST- 2022/09/20 03:23 [entrez] PHST- 2022/09/16 00:00 [pmc-release] AID - 356199 [pii] AID - SJG-29-12 [pii] AID - 10.4103/sjg.sjg_311_22 [doi] PST - ppublish SO - Saudi J Gastroenterol. 2023 Jan-Feb;29(1):12-20. doi: 10.4103/sjg.sjg_311_22.